These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8543152)

  • 1. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family.
    Herrscher RF; Kaplan MH; Lelsz DL; Das C; Scheuermann R; Tucker PW
    Genes Dev; 1995 Dec; 9(24):3067-82. PubMed ID: 8543152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation by a matrix associating region-binding protein. contextual requirements for the function of bright.
    Kaplan MH; Zong RT; Herrscher RF; Scheuermann RH; Tucker PW
    J Biol Chem; 2001 Jun; 276(24):21325-30. PubMed ID: 11294836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer.
    Lin D; Ippolito GC; Zong RT; Bryant J; Koslovsky J; Tucker P
    Mol Cancer; 2007 Mar; 6():23. PubMed ID: 17386101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator.
    Wang Z; Goldstein A; Zong RT; Lin D; Neufeld EJ; Scheuermann RH; Tucker PW
    Mol Cell Biol; 1999 Jan; 19(1):284-95. PubMed ID: 9858552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of matrix attachment regions and cut-like protein x/CCAAT-displacement protein and B cell regulator of IgH transcription binding sites flanking Ig V region genes.
    Goebel P; Montalbano A; Ayers N; Kompfner E; Dickinson L; Webb CF; Feeney AJ
    J Immunol; 2002 Sep; 169(5):2477-87. PubMed ID: 12193717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies.
    Zong RT; Das C; Tucker PW
    EMBO J; 2000 Aug; 19(15):4123-33. PubMed ID: 10921892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes.
    Kim D; Tucker PW
    Mol Cell Biol; 2006 Mar; 26(6):2187-201. PubMed ID: 16507996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HMG box-activating factors 1 and 2, two HMG box transcription factors that bind the human Ig heavy chain enhancer.
    Stevens S; Ordentlich P; Sen R; Kadesch T
    J Immunol; 1996 Oct; 157(8):3491-8. PubMed ID: 8871648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation.
    Nixon JC; Rajaiya J; Webb CF
    J Biol Chem; 2004 Dec; 279(50):52465-72. PubMed ID: 15456761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REKLES is an ARID3-restricted multifunctional domain.
    Kim D; Probst L; Das C; Tucker PW
    J Biol Chem; 2007 May; 282(21):15768-77. PubMed ID: 17400556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.
    Park K; Atchison ML
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9804-8. PubMed ID: 1946405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor.
    Elmaleh N; Matthias P; Schaffner W
    Eur J Biochem; 1990 Feb; 187(3):507-13. PubMed ID: 2105887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ig/EBP-1: a ubiquitously expressed immunoglobulin enhancer binding protein that is similar to C/EBP and heterodimerizes with C/EBP.
    Roman C; Platero JS; Shuman J; Calame K
    Genes Dev; 1990 Aug; 4(8):1404-15. PubMed ID: 2121606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.
    Rajaiya J; Nixon JC; Ayers N; Desgranges ZP; Roy AL; Webb CF
    Mol Cell Biol; 2006 Jun; 26(12):4758-68. PubMed ID: 16738337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutually exclusive interaction of a novel matrix attachment region binding protein and the NF-muNR enhancer repressor. Implications for regulation of immunoglobulin heavy chain expression.
    Zong RT; Scheuermann RH
    J Biol Chem; 1995 Oct; 270(41):24010-8. PubMed ID: 7592598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a new ARID family transcription factor (Brightlike/ARID3C) that co-activates Bright/ARID3A-mediated immunoglobulin gene transcription.
    Tidwell JA; Schmidt C; Heaton P; Wilson V; Tucker PW
    Mol Immunol; 2011 Oct; 49(1-2):260-72. PubMed ID: 21955986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.
    Shah PC; Bertolino E; Singh H
    EMBO J; 1997 Dec; 16(23):7105-17. PubMed ID: 9384588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of transcriptional control of the IgH locus: characterization, expression, and function of TF12/HEB homologs of the catfish.
    Hikima J; Cioffi CC; Middleton DL; Wilson MR; Miller NW; Clem LW; Warr GW
    J Immunol; 2004 Nov; 173(9):5476-84. PubMed ID: 15494495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ETS-core binding factor: a common composite motif in antigen receptor gene enhancers.
    Erman B; Cortes M; Nikolajczyk BS; Speck NA; Sen R
    Mol Cell Biol; 1998 Mar; 18(3):1322-30. PubMed ID: 9488447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
    Sepulveda MA; Emelyanov AV; Birshtein BK
    J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.